ロード中...
Differences in Response to Fetal Hemoglobin Induction Therapy in β-Thalassemia and Sickle Cell Disease
Inducers of fetal hemoglobin (HbF) have shown considerable promise in the treatment of sickle cell disease (SCD). However, the same agents have shown less clinical activity in β-thalassemia (β-Thal). To understand the basis of these differences in clinical effectiveness, we compared the effects of b...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2009
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2707824/ https://ncbi.nlm.nih.gov/pubmed/19346141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcmd.2009.02.006 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|